The analysis of specialists’ opinion on the implementation of concept of risk management in clinical trials of drugs

At the modern stage of the pharmaceutical industry development quality risk management becomes an integral part of all the processes of drug development and clinical trials (CT). Aim of paper is to study the opinion of competent experts in the field of CT of drugs and formation of strategic ways...

Full description

Bibliographic Details
Main Authors: E. A. Zupanets, V. Ye. Dobrova
Format: Article
Language:English
Published: Zaporozhye State Medical University 2016-06-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/77004/73897
_version_ 1818275491175464960
author E. A. Zupanets
V. Ye. Dobrova
author_facet E. A. Zupanets
V. Ye. Dobrova
author_sort E. A. Zupanets
collection DOAJ
description At the modern stage of the pharmaceutical industry development quality risk management becomes an integral part of all the processes of drug development and clinical trials (CT). Aim of paper is to study the opinion of competent experts in the field of CT of drugs and formation of strategic ways of risk management at the clinical site as well as to identify possible complications in the practical implementation of these approaches. Materials and methods: the survey of the expert group (17 people) to select the indicators and the parameters measuring the risks of CT at clinical site, as well as their acceptable levels. The assessment of survey results was done using non-parametric statistics methods. Results of research. There were established the differences of various stakeholders’ notion of conceptual content and practical importance of quality management and the application of risk-oriented approaches at the clinical site in relation to CT quality that can become an obstacle to their implementation. The introduction of risk-based monitoring into the system for CT management at the clinical site corresponds to the interests of all stakeholders involved in the study. General concernment of the customer’s representatives, regulatory authority and researchers should be an important basis for the implementation of the risk-based management at the clinical site. So, it is necessary to create a common understanding of the terminology, objectives and expected outcomes of risk management at the clinical site, as well as a clear allocation of the duties and responsibilities of each side. Conclusions. The expediency of the concept of risk management application at the clinical site, practical orientation, as well as the need to develop scientific and methodological approaches for its implementation, contributing to the formation of a common basis for action and coordinated interaction of stakeholders involved in the management of CT were proved.
first_indexed 2024-12-12T22:30:36Z
format Article
id doaj.art-76e23dce6ddf4041b71c535eccfb596d
institution Directory Open Access Journal
issn 2306-4145
2310-1210
language English
last_indexed 2024-12-12T22:30:36Z
publishDate 2016-06-01
publisher Zaporozhye State Medical University
record_format Article
series Zaporožskij Medicinskij Žurnal
spelling doaj.art-76e23dce6ddf4041b71c535eccfb596d2022-12-22T00:09:36ZengZaporozhye State Medical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102016-06-0139398The analysis of specialists’ opinion on the implementation of concept of risk management in clinical trials of drugsE. A. ZupanetsV. Ye. DobrovaAt the modern stage of the pharmaceutical industry development quality risk management becomes an integral part of all the processes of drug development and clinical trials (CT). Aim of paper is to study the opinion of competent experts in the field of CT of drugs and formation of strategic ways of risk management at the clinical site as well as to identify possible complications in the practical implementation of these approaches. Materials and methods: the survey of the expert group (17 people) to select the indicators and the parameters measuring the risks of CT at clinical site, as well as their acceptable levels. The assessment of survey results was done using non-parametric statistics methods. Results of research. There were established the differences of various stakeholders’ notion of conceptual content and practical importance of quality management and the application of risk-oriented approaches at the clinical site in relation to CT quality that can become an obstacle to their implementation. The introduction of risk-based monitoring into the system for CT management at the clinical site corresponds to the interests of all stakeholders involved in the study. General concernment of the customer’s representatives, regulatory authority and researchers should be an important basis for the implementation of the risk-based management at the clinical site. So, it is necessary to create a common understanding of the terminology, objectives and expected outcomes of risk management at the clinical site, as well as a clear allocation of the duties and responsibilities of each side. Conclusions. The expediency of the concept of risk management application at the clinical site, practical orientation, as well as the need to develop scientific and methodological approaches for its implementation, contributing to the formation of a common basis for action and coordinated interaction of stakeholders involved in the management of CT were proved.http://zmj.zsmu.edu.ua/article/view/77004/73897Сlinical TrialsDrug EvaluationRisk Assessment4-drugsInvestigational
spellingShingle E. A. Zupanets
V. Ye. Dobrova
The analysis of specialists’ opinion on the implementation of concept of risk management in clinical trials of drugs
Zaporožskij Medicinskij Žurnal
Сlinical Trials
Drug Evaluation
Risk Assessment
4-drugs
Investigational
title The analysis of specialists’ opinion on the implementation of concept of risk management in clinical trials of drugs
title_full The analysis of specialists’ opinion on the implementation of concept of risk management in clinical trials of drugs
title_fullStr The analysis of specialists’ opinion on the implementation of concept of risk management in clinical trials of drugs
title_full_unstemmed The analysis of specialists’ opinion on the implementation of concept of risk management in clinical trials of drugs
title_short The analysis of specialists’ opinion on the implementation of concept of risk management in clinical trials of drugs
title_sort analysis of specialists opinion on the implementation of concept of risk management in clinical trials of drugs
topic Сlinical Trials
Drug Evaluation
Risk Assessment
4-drugs
Investigational
url http://zmj.zsmu.edu.ua/article/view/77004/73897
work_keys_str_mv AT eazupanets theanalysisofspecialistsopinionontheimplementationofconceptofriskmanagementinclinicaltrialsofdrugs
AT vyedobrova theanalysisofspecialistsopinionontheimplementationofconceptofriskmanagementinclinicaltrialsofdrugs
AT eazupanets analysisofspecialistsopinionontheimplementationofconceptofriskmanagementinclinicaltrialsofdrugs
AT vyedobrova analysisofspecialistsopinionontheimplementationofconceptofriskmanagementinclinicaltrialsofdrugs